Minor differences in SDS height after the first year of treatment, which did not reach statistical significance, were observed in some genetic subgroups.
← all excerpts
Noonan syndrome spectrum disorders in real life: patient characteristics and response to growth hormone therapy in a genetically defined single-country multicenter cohort.
1
—
—